Brought to you by 
Watson to buy drug delivery company TheraTech in stock swap
Nov 1998
Executive Summary
Watson Pharmaceuticals (proprietary and off-patent drugs) will buy drug delivery company TheraTech in a stock swap that values TheraTech at about $300mm. The companies expect the transaction to close in the first quarter of 1999.
Deal Industry
- Biotechnology
-
Pharmaceuticals
-
Drug Delivery
- Controlled Release
- Pulmonary
- Transdermal
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Payment Includes Stock
- Full Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Watson to buy drug delivery company TheraTech in stock swap
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice